APO Research
Talk to an analyst

APO RESEARCH · REPORT

Isoxazoline Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Isoxazoline Drugs Industry Growth and Trends Forecast to 2032

29 December 202595 pages

Choose your research edition.

Industry ResearchIsoxazoline Drugs Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Isoxazoline Drugs Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Isoxazoline Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Isoxazoline Drugs Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Isoxazoline Drugs Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Isoxazoline Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Isoxazoline Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Isoxazoline Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Isoxazoline Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Isoxazoline Drugs include Zoetis Inc, Nissan Chemical Corporation, Merck Animal Health Inc., Elanco Animal Health Incorporated and Boehringer Ingelheim International GmbH, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Isoxazoline Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Isoxazoline Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Isoxazoline Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Isoxazoline Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Isoxazoline Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Isoxazoline Drugs Market by Company

Zoetis Inc

Nissan Chemical Corporation

Merck Animal Health Inc.

Elanco Animal Health Incorporated

Boehringer Ingelheim International GmbH

Isoxazoline Drugs Segment by Type

Sarolaner

Lotilaner

Fluralaner

Afoxolaner

Others

Isoxazoline Drugs Segment by Application

Dog

Cat

Others

Isoxazoline Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Isoxazoline Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Isoxazoline Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Isoxazoline Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Isoxazoline Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Isoxazoline Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Sarolaner Table 2. Major Company of Lotilaner Table 3. Major Company of Fluralaner Table 4. Major Company of Afoxolaner Table 5. Major Company of Others Table 6. Global Isoxazoline Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Isoxazoline Drugs Sales by Type (2021-2026) & (K Units) Table 8. Global Isoxazoline Drugs Sales Market Share in Volume by Type (2021-2026) Table 9. Global Isoxazoline Drugs Sales by Type (2021-2026) & (US$ Million) Table 10. Global Isoxazoline Drugs Sales Market Share in Value by Type (2021-2026) Table 11. Global Isoxazoline Drugs Price by Type (2021-2026) & (US$/Unit) Table 12. Global Isoxazoline Drugs Sales by Type (2027-2032) & (K Units) Table 13. Global Isoxazoline Drugs Sales Market Share in Volume by Type (2027-2032) Table 14. Global Isoxazoline Drugs Sales by Type (2027-2032) & (US$ Million) Table 15. Global Isoxazoline Drugs Sales Market Share in Value by Type (2027-2032) Table 16. Global Isoxazoline Drugs Price by Type (2027-2032) & (US$/Unit) Table 17. North America Isoxazoline Drugs Sales by Type (2021-2026) & (K Units) Table 18. North America Isoxazoline Drugs Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Isoxazoline Drugs Sales by Type (2021-2026) & (K Units) Table 20. Europe Isoxazoline Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Isoxazoline Drugs Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Isoxazoline Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Isoxazoline Drugs Sales by Type (2021-2026) & (K Units) Table 24. Latin America Isoxazoline Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Isoxazoline Drugs Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Isoxazoline Drugs Sales by Type (2021-2026) & (US$ Million) Table 27. Isoxazoline Drugs Industry Trends Table 28. Isoxazoline Drugs Industry Drivers Table 29. Isoxazoline Drugs Industry Opportunities and Challenges Table 30. Isoxazoline Drugs Industry Restraints Table 31. Global Isoxazoline Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Isoxazoline Drugs Revenue Market Share by Company (2021-2026) Table 33. Global Isoxazoline Drugs Sales by Company (2021-2026) & (K Units) Table 34. Global Isoxazoline Drugs Sales Share by Company (2021-2026) Table 35. Global Isoxazoline Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Isoxazoline Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Isoxazoline Drugs Major Company Production Sites and Headquarters Table 38. Global Isoxazoline Drugs Company, Product Type & Application Table 39. Global Isoxazoline Drugs Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Isoxazoline Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Isoxazoline Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Isoxazoline Drugs Sales by Region (2021-2026) & (K Units) Table 44. Global Isoxazoline Drugs Sales Market Share in Volume by Region (2021-2026) Table 45. Global Isoxazoline Drugs Sales by Region (2021-2026) & (US$ Million) Table 46. Global Isoxazoline Drugs Sales Market Share in Value by Region (2021-2026) Table 47. Global Isoxazoline Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Isoxazoline Drugs Sales by Region (2027-2032) & (K Units) Table 49. Global Isoxazoline Drugs Sales Market Share in Volume by Region (2027-2032) Table 50. Global Isoxazoline Drugs Sales by Region (2027-2032) & (US$ Million) Table 51. Global Isoxazoline Drugs Sales Market Share in Value by Region (2027-2032) Table 52. Global Isoxazoline Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Isoxazoline Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Isoxazoline Drugs Sales by Application (2021-2026) & (K Units) Table 55. Global Isoxazoline Drugs Sales Market Share in Volume by Application (2021-2026) Table 56. Global Isoxazoline Drugs Sales by Application (2021-2026) & (US$ Million) Table 57. Global Isoxazoline Drugs Sales Market Share in Value by Application (2021-2026) Table 58. Global Isoxazoline Drugs Price by Application (2021-2026) & (US$/Unit) Table 59. Global Isoxazoline Drugs Sales by Application (2027-2032) & (K Units) Table 60. Global Isoxazoline Drugs Sales Market Share in Volume by Application (2027-2032) Table 61. Global Isoxazoline Drugs Sales by Application (2027-2032) & (US$ Million) Table 62. Global Isoxazoline Drugs Sales Market Share in Value by Application (2027-2032) Table 63. Global Isoxazoline Drugs Price by Application (2027-2032) & (US$/Unit) Table 64. North America Isoxazoline Drugs Sales by Application (2021-2026) & (K Units) Table 65. North America Isoxazoline Drugs Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Isoxazoline Drugs Sales by Application (2021-2026) & (K Units) Table 67. Europe Isoxazoline Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Isoxazoline Drugs Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Isoxazoline Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Isoxazoline Drugs Sales by Application (2021-2026) & (K Units) Table 71. Latin America Isoxazoline Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Isoxazoline Drugs Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Isoxazoline Drugs Sales by Application (2021-2026) & (US$ Million) Table 74. Zoetis Inc Company Information Table 75. Zoetis Inc Business Overview Table 76. Zoetis Inc Isoxazoline Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Zoetis Inc Isoxazoline Drugs Product Portfolio Table 78. Zoetis Inc Recent Development Table 79. Nissan Chemical Corporation Company Information Table 80. Nissan Chemical Corporation Business Overview Table 81. Nissan Chemical Corporation Isoxazoline Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Nissan Chemical Corporation Isoxazoline Drugs Product Portfolio Table 83. Nissan Chemical Corporation Recent Development Table 84. Merck Animal Health Inc. Company Information Table 85. Merck Animal Health Inc. Business Overview Table 86. Merck Animal Health Inc. Isoxazoline Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Merck Animal Health Inc. Isoxazoline Drugs Product Portfolio Table 88. Merck Animal Health Inc. Recent Development Table 89. Elanco Animal Health Incorporated Company Information Table 90. Elanco Animal Health Incorporated Business Overview Table 91. Elanco Animal Health Incorporated Isoxazoline Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Elanco Animal Health Incorporated Isoxazoline Drugs Product Portfolio Table 93. Elanco Animal Health Incorporated Recent Development Table 94. Boehringer Ingelheim International GmbH Company Information Table 95. Boehringer Ingelheim International GmbH Business Overview Table 96. Boehringer Ingelheim International GmbH Isoxazoline Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Boehringer Ingelheim International GmbH Isoxazoline Drugs Product Portfolio Table 98. Boehringer Ingelheim International GmbH Recent Development Table 99. North America Isoxazoline Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 100. North America Isoxazoline Drugs Sales by Country (2021-2026) & (K Units) Table 101. North America Isoxazoline Drugs Sales Market Share by Country (2021-2026) Table 102. North America Isoxazoline Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 103. North America Isoxazoline Drugs Sales Market Share Forecast by Country (2027-2032) Table 104. North America Isoxazoline Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 105. North America Isoxazoline Drugs Market Size by Country (2021-2026) & (US$ Million) Table 106. North America Isoxazoline Drugs Market Share by Country (2021-2026) Table 107. North America Isoxazoline Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 108. North America Isoxazoline Drugs Market Share Forecast by Country (2027-2032) Table 109. Europe Isoxazoline Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 110. Europe Isoxazoline Drugs Sales by Country (2021-2026) & (K Units) Table 111. Europe Isoxazoline Drugs Sales Market Share by Country (2021-2026) Table 112. Europe Isoxazoline Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 113. Europe Isoxazoline Drugs Sales Market Share Forecast by Country (2027-2032) Table 114. Europe Isoxazoline Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 115. Europe Isoxazoline Drugs Market Size by Country (2021-2026) & (US$ Million) Table 116. Europe Isoxazoline Drugs Market Share by Country (2021-2026) Table 117. Europe Isoxazoline Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 118. Europe Isoxazoline Drugs Market Share Forecast by Country (2027-2032) Table 119. Asia-Pacific Isoxazoline Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 120. Asia-Pacific Isoxazoline Drugs Sales by Country (2021-2026) & (K Units) Table 121. Asia-Pacific Isoxazoline Drugs Sales Market Share by Country (2021-2026) Table 122. Asia-Pacific Isoxazoline Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 123. Asia-Pacific Isoxazoline Drugs Sales Market Share Forecast by Country (2027-2032) Table 124. Asia-Pacific Isoxazoline Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 125. Asia-Pacific Isoxazoline Drugs Market Size by Country (2021-2026) & (US$ Million) Table 126. Asia-Pacific Isoxazoline Drugs Market Share by Country (2021-2026) Table 127. Asia-Pacific Isoxazoline Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 128. Asia-Pacific Isoxazoline Drugs Market Share Forecast by Country (2027-2032) Table 129. Latin America Isoxazoline Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 130. Latin America Isoxazoline Drugs Sales by Country (2021-2026) & (K Units) Table 131. Latin America Isoxazoline Drugs Sales Market Share by Country (2021-2026) Table 132. Latin America Isoxazoline Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 133. Latin America Isoxazoline Drugs Sales Market Share Forecast by Country (2027-2032) Table 134. Latin America Isoxazoline Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. Latin America Isoxazoline Drugs Market Size by Country (2021-2026) & (US$ Million) Table 136. Latin America Isoxazoline Drugs Market Share by Country (2021-2026) Table 137. Latin America Isoxazoline Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. Latin America Isoxazoline Drugs Market Share Forecast by Country (2027-2032) Table 139. Middle East and Africa Isoxazoline Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 140. Middle East and Africa Isoxazoline Drugs Sales by Country (2021-2026) & (K Units) Table 141. Middle East and Africa Isoxazoline Drugs Sales Market Share by Country (2021-2026) Table 142. Middle East and Africa Isoxazoline Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 143. Middle East and Africa Isoxazoline Drugs Sales Market Share Forecast by Country (2027-2032) Table 144. Middle East and Africa Isoxazoline Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. Middle East and Africa Isoxazoline Drugs Market Size by Country (2021-2026) & (US$ Million) Table 146. Middle East and Africa Isoxazoline Drugs Market Share by Country (2021-2026) Table 147. Middle East and Africa Isoxazoline Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. Middle East and Africa Isoxazoline Drugs Market Share Forecast by Country (2027-2032) Table 149. Key Raw Materials Table 150. Raw Materials Key Suppliers Table 151. Isoxazoline Drugs Distributors List Table 152. Isoxazoline Drugs Customers List Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources Table 156. Primary Sources List of Figures Figure 1. Isoxazoline Drugs Image Figure 2. Global Isoxazoline Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Isoxazoline Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Isoxazoline Drugs Sales (2021-2032) & (K Units) Figure 5. Sarolaner Image Figure 6. Global Sarolaner Sales YoY Growth (2021-2032) & (K Units) Figure 7. Lotilaner Image Figure 8. Global Lotilaner Sales YoY Growth (2021-2032) & (K Units) Figure 9. Fluralaner Image Figure 10. Global Fluralaner Sales YoY Growth (2021-2032) & (K Units) Figure 11. Afoxolaner Image Figure 12. Global Afoxolaner Sales YoY Growth (2021-2032) & (K Units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Isoxazoline Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Isoxazoline Drugs Market Share by Type 2025 VS 2032 Figure 17. North America Isoxazoline Drugs Sales Market Share in Volume by Type in 2025 Figure 18. North America Isoxazoline Drugs Sales Market Share in Value by Type in 2025 Figure 19. Europe Isoxazoline Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Europe Isoxazoline Drugs Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Isoxazoline Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Isoxazoline Drugs Sales Market Share in Value by Type in 2025 Figure 23. Latin America Isoxazoline Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Isoxazoline Drugs Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Isoxazoline Drugs Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Isoxazoline Drugs Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Isoxazoline Drugs Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Dog Image Figure 30. Global Dog Sales YoY Growth (2021-2032) & (K Units) Figure 31. Cat Image Figure 32. Global Cat Sales YoY Growth (2021-2032) & (K Units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global Isoxazoline Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Isoxazoline Drugs Market Share by Application 2025 VS 2032 Figure 37. North America Isoxazoline Drugs Sales Market Share in Volume by Application in 2025 Figure 38. North America Isoxazoline Drugs Sales Market Share in Value by Application in 2025 Figure 39. Europe Isoxazoline Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Europe Isoxazoline Drugs Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Isoxazoline Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Isoxazoline Drugs Sales Market Share in Value by Application in 2025 Figure 43. Latin America Isoxazoline Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Isoxazoline Drugs Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Isoxazoline Drugs Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Isoxazoline Drugs Sales Market Share in Value by Application in 2025 Figure 47. North America Isoxazoline Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America Isoxazoline Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Isoxazoline Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Isoxazoline Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Isoxazoline Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe Isoxazoline Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Isoxazoline Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Isoxazoline Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Isoxazoline Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific Isoxazoline Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Isoxazoline Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Isoxazoline Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Isoxazoline Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America Isoxazoline Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Isoxazoline Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Isoxazoline Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Isoxazoline Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa Isoxazoline Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Isoxazoline Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Isoxazoline Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Isoxazoline Drugs Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Isoxazoline Drugs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Sarolaner
  • Lotilaner
  • Fluralaner
  • Afoxolaner
  • Others
Applications
  • Dog
  • Cat
  • Others
Companies covered
  • Zoetis Inc
  • Nissan Chemical Corporation
  • Merck Animal Health Inc.
  • Elanco Animal Health Incorporated
  • Boehringer Ingelheim International GmbH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Isoxazoline Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Isoxazoline Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Isoxazoline Drugs Market by Type
  6. 1.3.1 Sarolaner
  7. 1.3.2 Lotilaner
  8. 1.3.3 Fluralaner
  9. 1.3.4 Afoxolaner
  10. 1.3.5 Others
  11. 1.4 Global Isoxazoline Drugs Market Size by Type
  12. 1.4.1 Global Isoxazoline Drugs Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Isoxazoline Drugs Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Isoxazoline Drugs Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Isoxazoline Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Isoxazoline Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Isoxazoline Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Isoxazoline Drugs Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Isoxazoline Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Isoxazoline Drugs Industry Trends
  2. 2.2 Isoxazoline Drugs Industry Drivers
  3. 2.3 Isoxazoline Drugs Industry Opportunities and Challenges
  4. 2.4 Isoxazoline Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Isoxazoline Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Isoxazoline Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Isoxazoline Drugs Price (2021-2026)
  4. 3.4 Global Isoxazoline Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Isoxazoline Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Isoxazoline Drugs Company, Product Type & Application
  7. 3.7 Global Isoxazoline Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Isoxazoline Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Isoxazoline Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Isoxazoline Drugs Tier 1, Tier 2, and Tier 3
4 Isoxazoline Drugs Regional Status and Outlook
  1. 4.1 Global Isoxazoline Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Isoxazoline Drugs Historic Market Size by Region
  3. 4.2.1 Global Isoxazoline Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Isoxazoline Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Isoxazoline Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Isoxazoline Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Isoxazoline Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Isoxazoline Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Isoxazoline Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Isoxazoline Drugs by Application
  1. 5.1 Isoxazoline Drugs Market by Application
  2. 5.1.1 Dog
  3. 5.1.2 Cat
  4. 5.1.3 Others
  5. 5.2 Global Isoxazoline Drugs Market Size by Application
  6. 5.2.1 Global Isoxazoline Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Isoxazoline Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Isoxazoline Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Isoxazoline Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Isoxazoline Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Isoxazoline Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Isoxazoline Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Isoxazoline Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Zoetis Inc
  2. 6.1.1 Zoetis Inc Company Information
  3. 6.1.2 Zoetis Inc Business Overview
  4. 6.1.3 Zoetis Inc Isoxazoline Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Zoetis Inc Isoxazoline Drugs Product Portfolio
  6. 6.1.5 Zoetis Inc Recent Developments
  7. 6.2 Nissan Chemical Corporation
  8. 6.2.1 Nissan Chemical Corporation Company Information
  9. 6.2.2 Nissan Chemical Corporation Business Overview
  10. 6.2.3 Nissan Chemical Corporation Isoxazoline Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Nissan Chemical Corporation Isoxazoline Drugs Product Portfolio
  12. 6.2.5 Nissan Chemical Corporation Recent Developments
  13. 6.3 Merck Animal Health Inc.
  14. 6.3.1 Merck Animal Health Inc. Company Information
  15. 6.3.2 Merck Animal Health Inc. Business Overview
  16. 6.3.3 Merck Animal Health Inc. Isoxazoline Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merck Animal Health Inc. Isoxazoline Drugs Product Portfolio
  18. 6.3.5 Merck Animal Health Inc. Recent Developments
  19. 6.4 Elanco Animal Health Incorporated
  20. 6.4.1 Elanco Animal Health Incorporated Company Information
  21. 6.4.2 Elanco Animal Health Incorporated Business Overview
  22. 6.4.3 Elanco Animal Health Incorporated Isoxazoline Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Elanco Animal Health Incorporated Isoxazoline Drugs Product Portfolio
  24. 6.4.5 Elanco Animal Health Incorporated Recent Developments
  25. 6.5 Boehringer Ingelheim International GmbH
  26. 6.5.1 Boehringer Ingelheim International GmbH Company Information
  27. 6.5.2 Boehringer Ingelheim International GmbH Business Overview
  28. 6.5.3 Boehringer Ingelheim International GmbH Isoxazoline Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Boehringer Ingelheim International GmbH Isoxazoline Drugs Product Portfolio
  30. 6.5.5 Boehringer Ingelheim International GmbH Recent Developments
7 North America by Country
  1. 7.1 North America Isoxazoline Drugs Sales by Country
  2. 7.1.1 North America Isoxazoline Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Isoxazoline Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Isoxazoline Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Isoxazoline Drugs Market Size by Country
  6. 7.2.1 North America Isoxazoline Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Isoxazoline Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Isoxazoline Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Isoxazoline Drugs Sales by Country
  2. 8.1.1 Europe Isoxazoline Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Isoxazoline Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Isoxazoline Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Isoxazoline Drugs Market Size by Country
  6. 8.2.1 Europe Isoxazoline Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Isoxazoline Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Isoxazoline Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Isoxazoline Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Isoxazoline Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Isoxazoline Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Isoxazoline Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Isoxazoline Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Isoxazoline Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Isoxazoline Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Isoxazoline Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Isoxazoline Drugs Sales by Country
  2. 10.1.1 South America Isoxazoline Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Isoxazoline Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Isoxazoline Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Isoxazoline Drugs Market Size by Country
  6. 10.2.1 South America Isoxazoline Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Isoxazoline Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Isoxazoline Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Isoxazoline Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Isoxazoline Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Isoxazoline Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Isoxazoline Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Isoxazoline Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Isoxazoline Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Isoxazoline Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Isoxazoline Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Isoxazoline Drugs Value Chain Analysis
  2. 12.1.1 Isoxazoline Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Isoxazoline Drugs Production Mode & Process
  7. 12.2 Isoxazoline Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Isoxazoline Drugs Distributors
  10. 12.2.3 Isoxazoline Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst